SBLENDORIO GLENN has filed 16 insider transactions across 3 companies since May 2023.
Most recent transaction: a grant/award of 8300 shares of Mineralys Therapeutics, Inc. ($MLYS) on February 19, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | SBLENDORIO GLENN | Director | A | Stock Option | 8300 | $0.00 | 8,300.0000 | 79,139,956 | 9999.99% | 0.01% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | SBLENDORIO GLENN | Director | A | Common Stock | 6200 | $0.00 | 6,200.0000 | 79,139,956 | 9999.99% | 0.01% |
| Jan. 5, 2026 | 4D Molecular Therapeutics, Inc. | $FDMT | SBLENDORIO GLENN | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 57,135,075 | 9999.99% | 0.08% |
| June 5, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | SBLENDORIO GLENN | Not found | A | Common Stock | 20414 | $0.00 | 115,857.0000 | 300,116,081 | 21.39% | 0.01% |
| June 5, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | SBLENDORIO GLENN | Not found | A | Stock Options (right to buy) | 74872 | $0.00 | 74,872.0000 | 300,116,081 | 9999.99% | 0.02% |
| Feb. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | SBLENDORIO GLENN | Director | A | Stock Option | 32900 | $0.00 | 32,900.0000 | 49,835,637 | 9999.99% | 0.07% |
| June 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | SBLENDORIO GLENN | Not found | A | Common Stock | 11847 | $0.00 | 95,443.0000 | 295,164,515 | 14.17% | 0.00% |
| June 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | SBLENDORIO GLENN | Not found | A | Stock Options (right to buy) | 42467 | $0.00 | 42,467.0000 | 295,164,515 | 9999.99% | 0.01% |
| May 22, 2024 | Mineralys Therapeutics, Inc. | $MLYS | SBLENDORIO GLENN | Director | A | Stock Option | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | SBLENDORIO GLENN | Not found | M | Common Stock | 15000 | $2.80 | 83,596.0000 | 295,164,515 | 21.87% | 0.01% |
| March 7, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | SBLENDORIO GLENN | Not found | M | Stock Options (right to buy) | 15000 | $0.00 | 0.0000 | 295,164,515 | 100.00% | 0.01% |
| Sept. 13, 2023 | Mineralys Therapeutics, Inc. | $MLYS | SBLENDORIO GLENN | Director | A | Stock Option | 44000 | $0.00 | 44,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | SBLENDORIO GLENN | Director | A | Stock Options (right to buy) | 30474 | $0.00 | 30,474.0000 | 289,057,198 | 9999.99% | 0.01% |
| June 8, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | SBLENDORIO GLENN | Director | A | Common Stock | 8584 | $0.00 | 95,303.0000 | 289,057,198 | 9.90% | 0.00% |
| May 18, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | SBLENDORIO GLENN | Director | M | Common Stock | 15000 | $3.32 | 86,719.0000 | 289,057,198 | 20.91% | 0.01% |
| May 18, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | SBLENDORIO GLENN | Director | M | Stock Options (right to buy) | 15000 | $0.00 | 0.0000 | 289,057,198 | 100.00% | 0.01% |